|
97 |
Presentng a new direction for COVID-19 and cancer treatment
HOT
2024-03-12
2572
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
2572 |
|
96 |
Adipo LABs’ practice of ‘humanity’ that transcends borders
HOT
2024-03-12
2507
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
2507 |
|
94 |
AdipoLABs CEO Han Sung-ho visits the National Cemetery
HOT
2024-03-12
2344
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
2344 |
|
93 |
“COVID-19 treatment needs a major shift to hyperthermia therapy.”
HOT
2024-03-12
2231
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
2231 |
|
92 |
“COVID-19 treatment needs a major shift to hyperthermia therapy.”
HOT
2024-03-12
2305
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
2305 |
|
91 |
“Angola, no exception to the COVID-19 threat, recognizes the value of REMISSION 1℃”
HOT
2024-03-12
2334
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
2334 |
|
90 |
'REMISSION 1℃’ to fight COVID-19 is exported worldwide
HOT
2024-03-12
2308
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
2308 |
|
89 |
‘REMISSION 1℃’ expected to be a ‘game changer’ in COVID-19 treatment
HOT
2024-03-12
2357
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
2357 |
|
88 |
Global COVID-19 Overcoming Collaboration Group ‘IVRA’ Launched, “Proposed Treatment Guide”
HOT
2024-03-12
2329
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
2329 |
|
87 |
World's first joint collaboration to overcome COVID-19 treatment, IVRA is launched.
HOT
2024-03-12
2404
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
2404 |
|
85 |
IVRA draws attention to presenting a new medical paradigm to overcome COVID-19
HOT
2024-02-21
2703
(주)아디포랩스
|
(주)아디포랩스 |
2024-02-21 |
2703 |
|
83 |
Establishment of IVRA with medical staff from 30 countries, “preparation of coronavirus treatment measures”
HOT
2024-02-21
2810
(주)아디포랩스
|
(주)아디포랩스 |
2024-02-21 |
2810 |